Skip to content

Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)

Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01683500
Enrollment
4
Registered
2012-09-11
Start date
2012-08-31
Completion date
2014-08-31
Last updated
2015-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcinosis Cutis in Connective Tissue Disease

Brief summary

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy. The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain, size of the calcinosis, of possible ulcers and intake of painkillers. * Trial with medical device

Detailed description

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy (medical device). The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain (questionnaire), size of the calcinosis (ultrasound and CT), new ulcers and intake of painkillers.

Interventions

DEVICEshock wave therapy with Modulith SLK (Storz)

Three sessions with shock wave therapy, interval of one week.

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age of 18 * Calcinosis cutis due to connective tissue disease * information about ESWT given * Patient understands the study and signs the informed consent

Exclusion criteria

* No ESWT done * cuagulopathy * sepsis * pregnancy * pace maker * severe disease in the opinion of the investigator * cardiac risk with NYHA III-IV * Ehlers-Danlos-Syndrome

Design outcomes

Primary

MeasureTime frame
change in painafter 6 weeks

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026